Medicine and Dentistry
Epidermal Growth Factor Receptor 2
88%
Gamma Urogastrone
88%
Patient
77%
Cells
66%
Lung Cancer
66%
Exon
66%
Next Generation Sequencing
22%
Toxicity
11%
Therapeutic Procedure
11%
Adverse Event
11%
Diseases
11%
Biological Marker
11%
Overall Survival
11%
Progression Free Survival
11%
Multiplex Polymerase Chain Reaction
11%
Pharmacology, Toxicology and Pharmaceutical Science
Gamma Urogastrone
88%
Epidermal Growth Factor Receptor 2
88%
Lung Cancer
66%
Clinical Trial
33%
Chemotherapy
22%
Drug Conjugate
22%
Trastuzumab Emtansine
22%
Toxicity
11%
Adverse Event
11%
Diseases
11%
Biological Marker
11%
Progression Free Survival
11%
Overall Survival
11%
Biochemistry, Genetics and Molecular Biology
Mutation
100%
Epidermal Growth Factor Receptor
88%
Exon
66%
Trastuzumab Emtansine
22%
Electric Potential
11%
Overall Survival
11%
Multiplex Polymerase Chain Reaction
11%
Progression Free Survival
11%
Trastuzumab
11%